Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Tomas, Papajik"'
Autor:
Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber, Karel Indrak, Tomas Papajik
Publikováno v:
Biomedical Papers, Vol 167, Iss 3, Pp 236-245 (2023)
Background. Infectious complications during induction chemotherapy of acute myeloid leukaemia are very common. Prophylactic use of antibiotics however is an ongoing challenge in this situation due to bacterial multi-drug resistance. The aim of this s
Externí odkaz:
https://doaj.org/article/3f4604fbe33c4c9797523bde05b76384
Autor:
Lukas Semerad, Daniela Žáčková, Petra Belohlavkova, Jaroslava Voglova, Pavel Žák, Edgar Faber, Tomas Papajik, Ivana Skoumalova, Michal Karas, Pavel Jindra, Hana Klamová, Cyril Salek, Dana Srbová, Hana Zizkova, Lukas Stejskal, Olga Cerna, Eduard Cmunt, Petra Cicatkova, Anezka Kvetkova, Tomas Hornak, Ivana Jeziskova, Tomas Jurcek, Barbora Weinbergerová, Jirina Prochazkova, Katerina Machova Polakova, Adam Svobodnik, Radka Stepanova, Jiri Mayer
Publikováno v:
HemaSphere, Vol 7, p e70530bf (2023)
Externí odkaz:
https://doaj.org/article/e7c94ed4ac6546329523a51b5039e6a2
Autor:
Eva Kriegova, Regina Fillerova, Jiri Minarik, Jakub Savara, Jirina Manakova, Anna Petrackova, Martin Dihel, Jana Balcarkova, Petra Krhovska, Tomas Pika, Petr Gajdos, Marek Behalek, Michal Vasinek, Tomas Papajik
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Extramedullary disease (EMM) represents a rare, aggressive and mostly resistant phenotype of multiple myeloma (MM). EMM is frequently associated with high-risk cytogenetics, but their complex genomic architecture is largely unexplored. We us
Externí odkaz:
https://doaj.org/article/37daeaba58954dc38da078cfcf51a94f
Autor:
Zuzana Mikulkova, Gayane Manukyan, Peter Turcsanyi, Milos Kudelka, Renata Urbanova, Jakub Savara, Eliska Ochodkova, Yvona Brychtova, Jan Molinsky, Martin Simkovic, David Starostka, Jan Novak, Ondrej Janca, Martin Dihel, Pavlina Ryznerova, Lekaa Mohammad, Tomas Papajik, Eva Kriegova
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract The tissue microenvironment in chronic lymphocytic leukaemia (CLL) plays a key role in the pathogenesis of CLL, but the complex blood microenvironment in CLL has not yet been fully characterised. Therefore, immunophenotyping of circulating i
Externí odkaz:
https://doaj.org/article/def86669326e46929974b57867c48612
Autor:
Vit Prochazka, Heidi Mocikova, Alice Sykorova, Jana Markova, Marie Lukášová, Lubica Gaherova, Alexandra Kredatusova, Eva Kriegova, Maria Maco, Tomas Kozak, David Belada, Tomas Papajik
Publikováno v:
HemaSphere, Vol 6, Pp 21-21 (2022)
Externí odkaz:
https://doaj.org/article/1d9c54a116704f7d8c18c3786ca6f9f9
Autor:
Jan Grohmann, Alexandra Kredatusova, Jana Navratilova, Veronika Hanackova, Helena Urbankova, Vit Prochazka, Tomas Papajik
Publikováno v:
HemaSphere, Vol 6, Pp 17-17 (2022)
Externí odkaz:
https://doaj.org/article/d575e7ef41014f9a8b399712c184e047
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Inhibitors of B-cell receptor signaling, ibrutinib and idelalisib, and BCL-2 antagonist, venetoclax, have become the mainstay of treatment for chronic lymphocytic leukemia (CLL). Despite significant efficacy in most CLL patients, some patients develo
Externí odkaz:
https://doaj.org/article/7e4b32f8464f406cb9c64c48297cb66a
Autor:
Gayane Manukyan, Tomas Papajik, Zuzana Mikulkova, Renata Urbanova, Veronika Smotkova Kraiczova, Jakub Savara, Milos Kudelka, Peter Turcsanyi, Eva Kriegova
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Despite the shared pattern of surface antigens, neoplastic cells in chronic lymphocytic leukemia (CLL) are highly heterogeneous in CD5 expression, a marker linked to a proliferative pool of neoplastic cells. To further characterize CD5high and CD5low
Externí odkaz:
https://doaj.org/article/37eb7bf4416c48a69a1de4a8a140e415
Publikováno v:
British Journal of Haematology. 199:371-381
Germline pathogenic ATM (ataxia-telangiectasia mutated) variants are associated with the risk of multiple cancers; however, genetic testing reveals a large number of ATM variants of uncertain significance (VUS). Here, we studied germline ATM variants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1de1a51d60217b8091930c0b76e3ce94
https://doi.org/10.1111/bjh.18419
https://doi.org/10.1111/bjh.18419
Autor:
Anna Petrackova, Michal Vasinek, Lenka Sedlarikova, Tereza Dyskova, Petra Schneiderova, Tomas Novosad, Tomas Papajik, Eva Kriegova
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
The insufficient standardization of diagnostic next-generation sequencing (NGS) still limits its implementation in clinical practice, with the correct detection of mutations at low variant allele frequencies (VAF) facing particular challenges. We add
Externí odkaz:
https://doaj.org/article/d76c193bd24a46b6b8a3a5b687a45983